Search

Your search keyword '"Cimmino, Flora"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Cimmino, Flora" Remove constraint Author: "Cimmino, Flora"
194 results on '"Cimmino, Flora"'

Search Results

2. Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

3. FGFR1 is a potential therapeutic target in neuroblastoma

5. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

6. PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

7. Computational nucleus specificity for holographic tomography in flow cytometry

9. Data from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

10. Supplementary Table 1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

11. Supplementary Figure S4 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

12. Supplementary Materials and Methods from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

13. Supplementary Figures from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma

14. Data from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma

15. Supplementary Tables from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma

17. Supplementary Tables 1 - 12, Figures 1 - 5 from Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk

18. Toward the specificity in QPI 3D tomographic cell flow cytometry holography: recent achievements and perspectives in biomedical sciences

21. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1

23. FGFR1 is a Potential Therapeutic Target in Neuroblastoma

24. Additional file 4 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

25. Additional file 1 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

26. Additional file 1 of FGFR1 is a potential therapeutic target in neuroblastoma

27. Anti-tumor Activity of Cetuximab Plus Avelumab in Non-Small Cell Lung Cancer Patients Involves Innate Immunity Activation: Findings from the CAVE-Lung Trial

28. Stain-free nucleus identification in holographic learning flow cyto-tomography

29. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation ofOBFC1

30. Neuroblastoma Cells Classification Through Learning Approaches by Direct Analysis of Digital Holograms

31. Label-free microfluidic platform for blood analysis based on phase-contrast imaging

32. Tomographic flow cytometry as the key-enabling technology for label-free liquid biopsy

33. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1

36. Raw holograms based machine learning for cancer cells classification in microfluidics

40. Cover Picture: Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips (View 3/2020)

41. Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips

43. Association ofPARP1polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

44. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma

46. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor

47. Additional file 1: of HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia

48. Additional file 2: of HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia

49. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene

50. Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease

Catalog

Books, media, physical & digital resources